Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms

Detalhes bibliográficos
Autor(a) principal: Sun,Erlin
Data de Publicação: 2016
Outros Autores: Liang,Gehong, Wang,Lining, Wei,Wenjie, Lei,Mingde, Song,Shiduo, Han,Ruifa, Wang,Yubao, Qi,Wei
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000400365
Resumo: Abstract Aims We sought to characterize the antibiotic susceptibility of strains of Stenotrophomonas maltophilia isolated from clinical samples, and the role of Stenotrophomonas maltophilia biofilm in antibiotic resistance. Methods Fifty-one clinical Stenotrophomonas maltophilia isolates were obtained from patients with nosocomial infection in the surgical wards and ICUs of six general hospitals in Tianjin, China. In vitro models of Stenotrophomonas maltophilia biofilms were established and confirmed by scanning electron microscopy and fluorescence microscopy with silver staining. The minimal inhibitory concentrations and biofilm inhibitory concentrations of commonly used antibiotics were determined. Results 47 of 51 strains were resistant to three or more antibiotics. 42 of 51 strains formed Stenotrophomonas maltophilia biofilms in vitro. Stenotrophomonas maltophilia biofilm formation greatly reduced sensitivity to most tested antibiotics, but not to levofloxacin. However, in the presence of erythromycin scanning electron microscopy revealed that levofloxacin inhibited Stenotrophomonas maltophilia biofilm formation. Factorial ANOVA revealed that erythromycin enhanced susceptibility to levofloxacin, cefoperazone/sulbactam, and piperacillin (p < 0.05), and an ΔE model revealed that levofloxacin and erythromycin acted synergistically in biofilms, suggesting specific use of combined macrolide therapy may represent an effective treatment for Stenotrophomonas maltophilia infection. Conclusions Antibiotics could act synergistically to combat the protection conferred to clinical isolates of Stenotrophomonas maltophilia by biofilms. Macrolide antibiotics may be effective where used in combination.
id BSID-1_050b5d8720897ec35e70907a7a5d75cc
oai_identifier_str oai:scielo:S1413-86702016000400365
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilmsStenotrophomonas maltophiliaBiofilmAntibiotic resistanceNosocomialAbstract Aims We sought to characterize the antibiotic susceptibility of strains of Stenotrophomonas maltophilia isolated from clinical samples, and the role of Stenotrophomonas maltophilia biofilm in antibiotic resistance. Methods Fifty-one clinical Stenotrophomonas maltophilia isolates were obtained from patients with nosocomial infection in the surgical wards and ICUs of six general hospitals in Tianjin, China. In vitro models of Stenotrophomonas maltophilia biofilms were established and confirmed by scanning electron microscopy and fluorescence microscopy with silver staining. The minimal inhibitory concentrations and biofilm inhibitory concentrations of commonly used antibiotics were determined. Results 47 of 51 strains were resistant to three or more antibiotics. 42 of 51 strains formed Stenotrophomonas maltophilia biofilms in vitro. Stenotrophomonas maltophilia biofilm formation greatly reduced sensitivity to most tested antibiotics, but not to levofloxacin. However, in the presence of erythromycin scanning electron microscopy revealed that levofloxacin inhibited Stenotrophomonas maltophilia biofilm formation. Factorial ANOVA revealed that erythromycin enhanced susceptibility to levofloxacin, cefoperazone/sulbactam, and piperacillin (p < 0.05), and an ΔE model revealed that levofloxacin and erythromycin acted synergistically in biofilms, suggesting specific use of combined macrolide therapy may represent an effective treatment for Stenotrophomonas maltophilia infection. Conclusions Antibiotics could act synergistically to combat the protection conferred to clinical isolates of Stenotrophomonas maltophilia by biofilms. Macrolide antibiotics may be effective where used in combination.Brazilian Society of Infectious Diseases2016-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000400365Brazilian Journal of Infectious Diseases v.20 n.4 2016reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2016.04.002info:eu-repo/semantics/openAccessSun,ErlinLiang,GehongWang,LiningWei,WenjieLei,MingdeSong,ShiduoHan,RuifaWang,YubaoQi,Weieng2016-11-11T00:00:00Zoai:scielo:S1413-86702016000400365Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2016-11-11T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
title Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
spellingShingle Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
Sun,Erlin
Stenotrophomonas maltophilia
Biofilm
Antibiotic resistance
Nosocomial
title_short Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
title_full Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
title_fullStr Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
title_full_unstemmed Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
title_sort Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
author Sun,Erlin
author_facet Sun,Erlin
Liang,Gehong
Wang,Lining
Wei,Wenjie
Lei,Mingde
Song,Shiduo
Han,Ruifa
Wang,Yubao
Qi,Wei
author_role author
author2 Liang,Gehong
Wang,Lining
Wei,Wenjie
Lei,Mingde
Song,Shiduo
Han,Ruifa
Wang,Yubao
Qi,Wei
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sun,Erlin
Liang,Gehong
Wang,Lining
Wei,Wenjie
Lei,Mingde
Song,Shiduo
Han,Ruifa
Wang,Yubao
Qi,Wei
dc.subject.por.fl_str_mv Stenotrophomonas maltophilia
Biofilm
Antibiotic resistance
Nosocomial
topic Stenotrophomonas maltophilia
Biofilm
Antibiotic resistance
Nosocomial
description Abstract Aims We sought to characterize the antibiotic susceptibility of strains of Stenotrophomonas maltophilia isolated from clinical samples, and the role of Stenotrophomonas maltophilia biofilm in antibiotic resistance. Methods Fifty-one clinical Stenotrophomonas maltophilia isolates were obtained from patients with nosocomial infection in the surgical wards and ICUs of six general hospitals in Tianjin, China. In vitro models of Stenotrophomonas maltophilia biofilms were established and confirmed by scanning electron microscopy and fluorescence microscopy with silver staining. The minimal inhibitory concentrations and biofilm inhibitory concentrations of commonly used antibiotics were determined. Results 47 of 51 strains were resistant to three or more antibiotics. 42 of 51 strains formed Stenotrophomonas maltophilia biofilms in vitro. Stenotrophomonas maltophilia biofilm formation greatly reduced sensitivity to most tested antibiotics, but not to levofloxacin. However, in the presence of erythromycin scanning electron microscopy revealed that levofloxacin inhibited Stenotrophomonas maltophilia biofilm formation. Factorial ANOVA revealed that erythromycin enhanced susceptibility to levofloxacin, cefoperazone/sulbactam, and piperacillin (p < 0.05), and an ΔE model revealed that levofloxacin and erythromycin acted synergistically in biofilms, suggesting specific use of combined macrolide therapy may represent an effective treatment for Stenotrophomonas maltophilia infection. Conclusions Antibiotics could act synergistically to combat the protection conferred to clinical isolates of Stenotrophomonas maltophilia by biofilms. Macrolide antibiotics may be effective where used in combination.
publishDate 2016
dc.date.none.fl_str_mv 2016-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000400365
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000400365
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2016.04.002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.20 n.4 2016
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209243759640576